Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
National Viral Hepatitis Roundtable
NVHR, Hepatitis Education Project, NASTAD, Hep B United, and HepVu are joining together to gather insight and data
Since launch of ‘Hepatitis C: State of Medicaid Access’ in 2017, more than half still impose some form of illegal restriction
NVHR will host a free educational webinar about stigma as a barrier to HCV services among people who use drugs.
The National Viral Hepatitis Roundtable (NVHR) will be hosting a hepatitis C patient summit in early 2019.
Updated hepatitis C recommendations emphasize screening for key populations and treatment for all people living with HCV.
Hepatitis C affects more than just the liver. Hep C can have serious health impacts long before there are signs of advanced liver disease.
It is imperative that we act on the urgent need for additional federal funding and respond to the recent explosion of opioid use.
NVHR participated HHS’s webinar, Hidden Casualties: National Partners’ Response to the Opioid Epidemic and Infectious Diseases.
CDC Recommended HEPLISAV-B Vaccine; FDA Granted Orphan Drug Designation to Tenofovir Exalidex
NVHR is offering its third annual round of one-year hepatitis C program booster mini‐grants. Applications are due Monday, February 26, 2018
The Summit will address the need for greater patient engagement and patient leadership in the HCV field.
As Rev. Martin Luther King, Jr. once said: “Of all the forms of inequality, injustice in health care is the most shocking and inhumane.”
The project aims to increase awareness about HCV-related health conditions that occur outside the liver.
Dr. Jason Grebely provided an excellent debrief summarizing the main themes of the conference which we will try to summarize in this blog.
Please join the National Viral Hepatitis Roundtable for a webinar on December 13 on the topic of hepatitis C among pregnant women.
NMDC policy fails to list another potential penalty for a major offense: denial of lifesaving treatment for the deadly hepatitis C virus.
We are beginning to see the fruits of our efforts in eradicating this disease.
We welcome respectful discussions with us about these issues and why they matter to our efforts to eliminate hepatitis B and hepatitis C.
If we don’t take a stand against policies and rhetoric that fuel racial injustice, we aren’t truly fighting viral hepatitis.
The Senate proposes to repeal and replace Affordable Care that would imperil the health of 5 million Americans living with hepatitis B or C.
A prison sentence is often a death sentence -- whether from overdose, opiate withdrawal, or hepatitis C.
Policies and rhetoric that further racial injustice directly impact people living with hepatitis B and C.
Each organization has identified an aspect of the barriers to hepatitis C care faced by people who use drugs, and addresses these barriers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.